Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 106 results.
User Information
Export Records
  1. 1.   Novel pyrazolo[4,3-d]pyrimidine microtubule targeting agents (MTAs): Synthesis, structure-activity relationship, in vitro and in vivo evaluation as antitumor agents
  2. Islam, Farhana; Quadery, Tasdique M.; Bai,Ruoli; Luckett-Chastain, Lerin R.; Hamel,Ernest; Ihnat, Michael A.; Gangjee, Aleem
  3. Bioorganic & Medicinal Chemistry Letters. 2021, Jun 1; 41
  1. 2.   Tumour predisposition and cancer syndromes as models to study gene-environment interactions
  2. Carbone, Michele; Arron, Sarah T.; Beutler, Bruce; Bononi, Angela; Cavenee, Webster; Cleaver, James E.; Croce, Carlo M.; D'Andrea, Alan; Foulke, William D.; Gaudino, Giovanni; Groden, Joanna L.; Henske, Elizabeth P.; Hickson, Ian D.; Hwang, Paul M.; Kolodner, Richard D.; Mak, Tak W.; Malkin, David; Monnat, Raymond J. Jr Jr; Novelli, Flavia; Pass, Harvey; Petrini, John H.; Schmidt,Laura; Yang, Haining
  3. Nature reviews. Cancer. 2020, May 29;
  1. 3.   Kynurenine 3-Monooxygenase Inhibition during Acute Simian Immunodeficiency Virus Infection Lowers PD-1 Expression and Improves Post-Combination Antiretroviral Therapy CD4+ T Cell Counts and Body Weight
  2. Swainson, Louise A; Ahn, Haelee; Pajanirassa, Priya; Khetarpal, Vinod; Deleage,Claire; Estes,Jake; Hunt, Peter W; Munoz-Sanjuan, Ignacio; McCune, Joseph M
  3. Journal of immunology (Baltimore, Md. : 1950). 2019, AUG 15; 203(4): 899-910.
  1. 4.   Design, synthesis and preclinical evaluation of 5-methyl-N4-aryl-furo[2,3-d]pyrimidines as single agents with combination chemotherapy potential
  2. Devambatla, Ravi Kumar Vyas; Choudhary, Shruti; Ihnat, Michael; Hamel, Ernest; Mooberry, Susan L; Gangjee, Aleem
  3. Bioorganic & Medicinal Chemistry Letters. 2018, Oct 1; 28(18): 3085-3093.
  1. 5.   DNA Methyltransferase Inhibitor, Zebularine, Delays Tumor Growth and Induces Apoptosis in a Genetically Engineered Mouse Model of Breast Cancer
  2. Chen, M.; Shabashvili, D.; Nawab, A.; Yang, S. X.; Dyer, L. M.; Brown, K. D.; Hollingshead, M.; Hunter, K. W.; Kaye, F. J.; Hochwald, S. N.; Marquez, V. E.; Steeg, P.; Zajac-Kaye, M.
  3. Molecular Cancer Therapeutics. 2012, Feb; 11(2): 370-382.
  1. 6.   Solution Properties of Murine Leukemia Virus Gag Protein: Differences from HIV-1 Gag
  2. Datta, S. A. K.; Zuo, X. B.; Clark, P. K.; Campbell, S. J.; Wang, Y. X.; Rein, A.
  3. Journal of Virology. 2011, Dec; 85(23): 12733-12741.
  1. 7.   Highlights of 10 years of immunology in Nature Reviews Immunology
  2. Medzhitov, R.; Shevach, E. M.; Trinchieri, G.; Mellor, A. L.; Munn, D. H.; Gordon, S.; Libby, P.; Hansson, G. K.; Shortman, K.; Dong, C.; Gabrilovich, D.; Gabrysova, L.; Howes, A.; O'Garra, A.
  3. Nature Reviews Immunology. 2011, Oct; 11(10): 693-702.
  1. 8.   New Candidaspongiolides, Tedanolide Analogues That Selectively Inhibit Melanoma Cell Growth
  2. Whitson, E. L.; Pluchino, K. M.; Hall, M. D.; McMahon, J. B.; McKee, T. C.
  3. Organic Letters. 2011, Jul; 13(13): 3518-3521.
  1. 9.   The substrate specificity of Metarhizium anisopliae and Bos taurus carboxypeptidases A: Insights into their use as tools for the removal of affinity tags
  2. Austin, B. P.; Tozser, J.; Bagossi, P.; Tropea, J. E.; Waugh, D. S.
  3. Protein Expression and Purification. 2011, May; 77(1): 53-61.
  1. 10.   Gag Localization and Virus-Like Particle Release Mediated by the Matrix Domain of Human T-Lymphotropic Virus Type 1 Gag Are Less Dependent on Phosphatidylinositol-(4,5)-Bisphosphate than Those Mediated by the Matrix Domain of HIV-1 Gag
  2. Inlora, J.; Chukkapalli, V.; Derse, D.; Ono, A.
  3. Journal of Virology. 2011, Apr; 85(8): 3802-3810.
  1. 11.   FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer
  2. Watkins, S. K.; Zhu, Z. Q.; Riboldi, E.; Shafer-Weaver, K. A.; Stagliano, K. E. R.; Sklavos, M. M.; Ambs, S.; Yagita, H.; Hurwitz, A. A.
  3. Journal of Clinical Investigation. 2011, Apr; 121(4): 1361-1372.
  1. 12.   Apoptosis Is the Essential Target of Selective Pressure against p53, whereas Loss of Additional p53 Functions Facilitates Carcinoma Progression
  2. Lu, X. D. L. X. D.; Yang, C. Y.; Yin, C. Y.; Van Dyke, T.; Simin, K.
  3. Molecular Cancer Research. 2011, Apr; 9(4): 430-439.
  1. 13.   Myristate Exposure in the Human Immunodeficiency Virus Type 1 Matrix Protein Is Modulated by pH
  2. Fledderman, E. L.; Fujii, K.; Ghanam, R. H.; Waki, K.; Prevelige, P. E.; Freed, E. O.; Saad, J. S.
  3. Biochemistry. 2010, Nov; 49(44): 9551-9562.
  1. 14.   Click Reaction in Conjunction with Diazeniumdiolate Chemistry: Developing High-Load Nitric Oxide Donors
  2. Oladeinde, O. A.; Hong, S. Y.; Holland, R. J.; Maciag, A. E.; Keefer, L. K.; Saavedra, J. E.; N, urdikar
  3. Organic Letters. 2010, Oct; 12(19): 4256-4259.
  1. 15.   Impact of synchrotron radiation on macromolecular crystallography: a personal view
  2. Dauter, Z.; Jaskolski, M.; Wlodawer, A.
  3. Journal of Synchrotron Radiation. 2010, Jul; 17: 433-444.
  1. 16.   Activation of p73 and induction of Noxa by DNA damage requires NF-kappa B
  2. Martin, A. G.; Trama, J.; Crighton, D.; Ryan, K. M.; Fearnhead, H. O.
  3. Aging-Us. 2009, Mar; 1(3): 335-349.
  1. 17.   Urothelial Overexpression of Insulin-Like Growth Factor-1 Increases Susceptibility to p-Cresidine-Induced Bladder Carcinogenesis in Transgenic Mice
  2. Hursting, S. D.; Perkins, S. N.; Lavigne, J. A.; Beltran, L.; Haines, D. C.; Hill, H. L.; Alvord, W. G.; Barrett, J. C.; DiGiovanni, J.
  3. Molecular Carcinogenesis. 2009 48(8): 671-677.
  1. 18.   Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton
  2. Barkan, D.; Kleinman, H.; Simmons, J. L.; Asmussen, H.; Kamaraju, A. K.; Hoenorhoff, M. J.; Liu, Z. Y.; Costes, S. V.; Cho, E. H.; Lockett, S.; Khanna, C.; Chambers, A. F.; Green, J. E.
  3. Cancer Research. 2008 68(15): 6241-6250.
  1. 19.   Plasmacytoid dendritic cells mediate oral tolerance
  2. Goubier, A.; Dubois, B.; Gheit, H.; Joubert, G.; Villard-Truc, F.; Asselin-Paturel, C.; Trinchieri, G.; Kaiserlian, D.
  3. Immunity. 2008 29(3): 464-475.
  1. 20.   Activation of p16 Gene Silenced by DNA Methylation in Cancer Cells by Phosphoramidate Derivatives of 2 '-Deoxyzebularine
  2. Yoo, C. B.; Valente, R.; Congiatu, C.; Gavazza, F.; Angel, A.; Siddiqui, M. A.; Jones, P. A.; McGuigan, C.; Marquez, V. E.
  3. Journal of Medicinal Chemistry. 2008 51(23): 7593-7601.
  1. 21.   Proteomic analysis of protein expression changes in a model of gliomagenesis
  2. McBee, J. K.; Yu, L. R.; Kinoshita, Y.; Uo, T.; Beyer, R. P.; Veenstra, T. D.; Morrison, R. S.
  3. Proteomics Clinical Applications. 2007, Nov; 1(11): 1485-1498.
  1. 22.   Structure and activity of Yersinia pestis 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase as a novel target for the development of antiplague therapeutics
  2. Blaszczyk, J.; Li, Y.; Cherry, S.; Alexandratos, J.; Wu, Y.; Shaw, G.; Tropea, J. E.; Waugh, D. S.; Yan, H. G.; Ji, X. H.
  3. Acta Crystallographica Section D-Biological Crystallography. 2007, Nov; 63: 1169-1177.
  1. 23.   Candidaspongiolides, distinctive analogues of tedanolide from sponges of the genus Candidaspongia
  2. Meragelman, T. L.; Willis, R. H.; Woldemichael, G. M.; Heaton, A.; Murphy, P. T.; Snader, K. M.; Newman, D. J.; Van Soest, R.; Boyd, M. R.; Cardellina, J. H.; McKee, T. C.
  3. Journal of Natural Products. 2007, Jul; 70(7): 1133-1138.
  1. 24.   Stereochemical restraints revisited: how accurate are refinement targets and how much should protein structures be allowed to deviate from them?
  2. Jaskolski, M.; Gilski, M.; Dauter, Z.; Wlodawer, A.
  3. Acta Crystallographica Section D-Biological Crystallography. 2007, May; 63: 611-620.
  1. 25.   An insight into the sialome of the oriental rat flea, Xenopsylla cheopis (Rots)
  2. Andersen, J. F.; Hinnebusch, B. J.; Lucas, D. A.; Conrads, T. P.; Veenstra, T. D.; Pham, V. M.; Ribeiro, J. M. C.
  3. Bmc Genomics. 2007, Apr; 8
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel